论文部分内容阅读
目的观察补阳还五汤联合华法林治疗非瓣膜性心房颤动所致急性脑栓塞的临床疗效。方法选取2014年12月—2016年1月榆林市星元医院收治的非瓣膜性心房颤动所致急性脑栓塞患者60例,采用随机数字表法分为对照组和试验组,每组30例。对照组患者采用华法林治疗,试验组患者采用补阳还五汤联合华法林治疗。比较两组患者临床疗效。结果试验组患者临床疗效优于对照组(P<0.05)。结论补阳还五汤联合华法林治疗非瓣膜性心房颤动所致急性脑栓塞的临床疗效确切,安全性较高。
Objective To observe the clinical efficacy of Buyang Huanwu Decoction combined with warfarin in the treatment of acute cerebral embolism caused by nonvalvular atrial fibrillation. Methods Sixty patients with acute cerebral embolism caused by non-valvular atrial fibrillation in Xingyuan Hospital of Yulin City from December 2014 to January 2016 were randomly divided into control group and experimental group with 30 cases in each group. Patients in the control group were treated with warfarin, and patients in the test group were treated with Buyang Huanwu Decoction combined with warfarin. The clinical efficacy of the two groups was compared. Results The clinical efficacy of the experimental group was better than that of the control group (P <0.05). Conclusion The clinical efficacy of Buyang Huanwu Decoction combined with warfarin in the treatment of acute cerebral embolism caused by non-valvular atrial fibrillation is definite and safe.